NEW YORK (GenomeWeb) – AutoGenomics on Monday priced its planned initial public offering at between $11 and $13 per share, with anticipated net proceeds of up to $46.6 million. 

In an amended prospectus, the company said it plans to offer 3.75 million shares of its common stock in its IPO. It plans to list its shares on the Nasdaq Global Market under ticker symbol "AGMX." 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.